Literature DB >> 16937745

Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization.

Eric Macy1.   

Abstract

BACKGROUND: The safety and utility of penicillin skin testing (PST) in pregnant women with a history of penicillin allergy and group B streptococcus (GBS) colonization have not been studied.
OBJECTIVE: To document the safety and utility of PST in pregnant women with a history of penicillin allergy and GBS colonization.
METHODS: Pregnant GBS culture-positive women with a history compatible with an IgE-mediated or unknown reaction to a penicillin-class antibiotic were recruited for PST. If PST results were negative, penicillin-class antibiotics were recommended for GBS prophylaxis. Adverse reactions associated with PST or antibiotic use from the time of PST through delivery and 6 months post partum were reported.
RESULTS: In 56 enrolled patients, there were only 2 mild adverse reactions (4%) associated with PST and 3 positive PST results (5%). Of the 53 PST-negative patients, 47 (89%) received at least 1 course of penicillin. There were 2 delayed-onset rashes associated with the use of intrapartum penicillins and 1 immediate-onset rash with intrapartum vancomycin therapy in a PST-positive woman. There were 7 reactions (6%) associated with 122 antibiotic courses administered.
CONCLUSIONS: Penicillin skin testing can be performed safelyin pregnant women and, if the results are negative, allows penicillins to be used safely at delivery for GBS prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937745     DOI: 10.1016/S1081-1206(10)60007-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

1.  A 25-year-old woman reporting an allergy to penicillin.

Authors:  Lucas R Castellani; Wayne L Gold; Derek R MacFadden
Journal:  CMAJ       Date:  2015-04-20       Impact factor: 8.262

2.  Morbidity in Pregnant Women Associated with Unverified Penicillin Allergies, Antibiotic Use, and Group B Streptococcus Infections.

Authors:  Shilpa H Desai; Michael S Kaplan; Qiaoling Chen; Eric M Macy
Journal:  Perm J       Date:  2017-01-06

Review 3.  Antibiotic allergy labels in hospitalized and critically ill adults: A review of current impacts of inaccurate labelling.

Authors:  Rebekah Moran; Misha Devchand; Olivia Smibert; Jason A Trubiano
Journal:  Br J Clin Pharmacol       Date:  2019-01-11       Impact factor: 4.335

Review 4.  Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations.

Authors:  Karen M Anstey; Lulu Tsao; Iris M Otani
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

Review 5.  Penicillin and beta-lactam allergy: epidemiology and diagnosis.

Authors:  Eric Macy
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

6.  Choice of Prophylactic Antibiotics and Surgical Site Infections After Cesarean Delivery.

Authors:  Tetsuya Kawakita; Chun-Chih Huang; Helain J Landy
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

7.  Vancomycin during delivery hospitalizations for women with group B streptococcus.

Authors:  Cassandra R Duffy; Yongmei Huang; Maria Andrikopoulou; Conrad N Stern-Ascher; Jason D Wright; Mary E D'Alton; Alexander M Friedman
Journal:  J Matern Fetal Neonatal Med       Date:  2020-03-11

8.  The falling rate of positive penicillin skin tests from 1995 to 2007.

Authors:  Eric Macy; Michael Schatz; Ck Lin; Kwun-Yee Poon
Journal:  Perm J       Date:  2009

9.  Penicilloyl-polylysine stability and clinical use over time.

Authors:  Eric Macy; Ck Lin; Bruce Goldberg
Journal:  Perm J       Date:  2007

10.  Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use.

Authors:  Anna R Wolfson; Christian M Mancini; Aleena Banerji; Xiaoqing Fu; Allison S Bryant; Neelam A Phadke; Erica S Shenoy; Weaam Arman; Yuqing Zhang; Kimberly G Blumenthal
Journal:  J Allergy Clin Immunol Pract       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.